MXPA03003845A - Benzo'b! tiofenos y benzo'd! isotiazoles bajos en colesterol. - Google Patents
Benzo'b! tiofenos y benzo'd! isotiazoles bajos en colesterol.Info
- Publication number
- MXPA03003845A MXPA03003845A MXPA03003845A MXPA03003845A MXPA03003845A MX PA03003845 A MXPA03003845 A MX PA03003845A MX PA03003845 A MXPA03003845 A MX PA03003845A MX PA03003845 A MXPA03003845 A MX PA03003845A MX PA03003845 A MXPA03003845 A MX PA03003845A
- Authority
- MX
- Mexico
- Prior art keywords
- benzo
- isothiazoles
- thiophenes
- cholesterol lowering
- prophylaxis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00123826 | 2000-11-02 | ||
| PCT/EP2001/012451 WO2002036584A1 (en) | 2000-11-02 | 2001-10-26 | Cholesterol lowering benzo`b! thiophenes and benzo`d! isothiazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03003845A true MXPA03003845A (es) | 2003-07-28 |
Family
ID=8170270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03003845A MXPA03003845A (es) | 2000-11-02 | 2001-10-26 | Benzo'b! tiofenos y benzo'd! isotiazoles bajos en colesterol. |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US6951879B2 (es) |
| EP (1) | EP1334094B1 (es) |
| JP (1) | JP4012064B2 (es) |
| KR (1) | KR100545430B1 (es) |
| CN (1) | CN1261429C (es) |
| AR (1) | AR034271A1 (es) |
| AT (1) | ATE286042T1 (es) |
| AU (2) | AU2002214029B2 (es) |
| BR (1) | BR0115075A (es) |
| CA (1) | CA2426009C (es) |
| DE (1) | DE60108164T2 (es) |
| DK (1) | DK1334094T3 (es) |
| ES (1) | ES2233703T3 (es) |
| GT (1) | GT200100220A (es) |
| MX (1) | MXPA03003845A (es) |
| PA (1) | PA8531601A1 (es) |
| PE (1) | PE20020600A1 (es) |
| PT (1) | PT1334094E (es) |
| UY (1) | UY27009A1 (es) |
| WO (1) | WO2002036584A1 (es) |
| ZA (1) | ZA200302742B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03001269A (es) | 2000-08-16 | 2003-06-09 | Hoffmann La Roche | Nuevos derivados de aminociclohexano. |
| US7012077B2 (en) * | 2001-12-20 | 2006-03-14 | Hoffmann-La Roche Inc. | Substituted cyclohexane derivatives |
| EP1647549A1 (en) * | 2004-10-14 | 2006-04-19 | Laboratoire Theramex | Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents |
| AU2005299693B2 (en) * | 2004-10-26 | 2012-07-05 | Janssen Pharmaceutica, N.V. | Factor Xa compounds |
| EP1902023A4 (en) * | 2005-06-30 | 2009-08-12 | Bayer Cropscience Ag | IMPROVED PROCESS FOR PREPARING PHENYLALKYL SUBSTITUTED INSECTICIDE HETEROCYCLES (DISUBSTITUTED PROPENYL) |
| FR2913019A1 (fr) * | 2007-02-23 | 2008-08-29 | Cerep Sa | Composes heterocycliques comme agents anti-neoplasiques ou inhibiteurs de proliferation cellulaire |
| BRPI0820226A2 (pt) * | 2007-11-29 | 2015-06-16 | Ranbaxy Lab Ltd | Processo para o preparo de um 1,3-oxatiolana, para o preparo de lamivudina e para isolar lamivudina, lamivudina e composição farmacêutica |
| BRPI0820224A2 (pt) * | 2007-11-29 | 2015-06-16 | Ranbaxy Lab Ltd | Composto de fórmula iii ou seus estereoisômeros; processo para sua preparação e seu uso; uso de um composto de formula iii(a) ou iii(b) em um processo para a preparação de lamivudina de fórmula i(a) ou um composto de fórmula i(c); processo para preparação de lamivudina de fórmula i(a) |
| AU2011352378B2 (en) * | 2010-12-27 | 2016-08-04 | The Curators Of The University Of Missouri | Oxidosqualene cyclase as a protein target for anticancer therapeutics |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3598839A (en) * | 1969-06-30 | 1971-08-10 | Parke Davis & Co | Phenylbenzothiophene compounds |
| GR75101B (es) * | 1980-10-23 | 1984-07-13 | Pfizer | |
| GB8417559D0 (en) * | 1984-07-10 | 1984-08-15 | Pfizer Ltd | Anti-diarrhoeal agents |
| DE3905364A1 (de) | 1989-02-22 | 1990-08-23 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool |
| EP0530149A1 (de) * | 1991-08-30 | 1993-03-03 | Ciba-Geigy Ag | Schädlingsbekämpfungsmittel |
| US5482949A (en) * | 1993-03-19 | 1996-01-09 | Eli Lilly And Company | Sulfonate derivatives of 3-aroylbenzo[b]thiophenes |
| CA2190708A1 (en) * | 1995-12-08 | 1997-06-09 | Johannes Aebi | Aminoalkyl substituted benzo-heterocyclic compounds |
| CA2190699A1 (en) * | 1995-12-08 | 1997-06-09 | Johannes Aebi | Tertiary amines |
| UA56197C2 (uk) | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
-
2001
- 2001-10-26 EP EP01982445A patent/EP1334094B1/en not_active Expired - Lifetime
- 2001-10-26 ES ES01982445T patent/ES2233703T3/es not_active Expired - Lifetime
- 2001-10-26 DE DE60108164T patent/DE60108164T2/de not_active Expired - Lifetime
- 2001-10-26 MX MXPA03003845A patent/MXPA03003845A/es active IP Right Grant
- 2001-10-26 CA CA002426009A patent/CA2426009C/en not_active Expired - Fee Related
- 2001-10-26 JP JP2002539343A patent/JP4012064B2/ja not_active Expired - Fee Related
- 2001-10-26 PT PT01982445T patent/PT1334094E/pt unknown
- 2001-10-26 DK DK01982445T patent/DK1334094T3/da active
- 2001-10-26 AU AU2002214029A patent/AU2002214029B2/en not_active Ceased
- 2001-10-26 CN CNB018182046A patent/CN1261429C/zh not_active Expired - Fee Related
- 2001-10-26 WO PCT/EP2001/012451 patent/WO2002036584A1/en active IP Right Grant
- 2001-10-26 AU AU1402902A patent/AU1402902A/xx active Pending
- 2001-10-26 BR BR0115075-8A patent/BR0115075A/pt not_active Application Discontinuation
- 2001-10-26 KR KR1020037006161A patent/KR100545430B1/ko not_active IP Right Cessation
- 2001-10-26 AT AT01982445T patent/ATE286042T1/de active
- 2001-10-30 PE PE2001001078A patent/PE20020600A1/es not_active Application Discontinuation
- 2001-10-31 US US09/999,424 patent/US6951879B2/en not_active Expired - Fee Related
- 2001-10-31 GT GT200100220A patent/GT200100220A/es unknown
- 2001-11-01 UY UY27009A patent/UY27009A1/es not_active Application Discontinuation
- 2001-11-01 PA PA20018531601A patent/PA8531601A1/es unknown
- 2001-11-01 AR ARP010105115A patent/AR034271A1/es unknown
-
2003
- 2003-04-08 ZA ZA200302742A patent/ZA200302742B/en unknown
-
2005
- 2005-07-08 US US11/178,164 patent/US7173043B2/en not_active Expired - Fee Related
-
2006
- 2006-12-06 US US11/634,573 patent/US7449483B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1334094B1 (en) | 2004-12-29 |
| US7449483B2 (en) | 2008-11-11 |
| PE20020600A1 (es) | 2002-07-08 |
| US7173043B2 (en) | 2007-02-06 |
| CN1471522A (zh) | 2004-01-28 |
| JP4012064B2 (ja) | 2007-11-21 |
| US20070099985A1 (en) | 2007-05-03 |
| DE60108164T2 (de) | 2006-03-02 |
| PT1334094E (pt) | 2005-05-31 |
| GT200100220A (es) | 2002-07-04 |
| BR0115075A (pt) | 2003-07-29 |
| CA2426009C (en) | 2008-10-07 |
| CN1261429C (zh) | 2006-06-28 |
| AR034271A1 (es) | 2004-02-18 |
| EP1334094A1 (en) | 2003-08-13 |
| ZA200302742B (en) | 2004-07-08 |
| KR20030045166A (ko) | 2003-06-09 |
| US20020086891A1 (en) | 2002-07-04 |
| WO2002036584A1 (en) | 2002-05-10 |
| ATE286042T1 (de) | 2005-01-15 |
| KR100545430B1 (ko) | 2006-01-24 |
| US6951879B2 (en) | 2005-10-04 |
| JP2004513124A (ja) | 2004-04-30 |
| DK1334094T3 (da) | 2005-05-02 |
| PA8531601A1 (es) | 2003-02-14 |
| US20050267200A1 (en) | 2005-12-01 |
| ES2233703T3 (es) | 2005-06-16 |
| DE60108164D1 (de) | 2005-02-03 |
| AU1402902A (en) | 2002-05-15 |
| CA2426009A1 (en) | 2002-05-10 |
| AU2002214029B2 (en) | 2004-12-23 |
| UY27009A1 (es) | 2002-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL183953A0 (en) | Method of reducing oxidant induced damage of a food product, a pharmaceutical, or stored blood | |
| WO2002048124A3 (en) | Piperazine derivatives | |
| HK1165729A1 (en) | Krill and or marine extracts for prevention and or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport | |
| WO2004043954A3 (en) | Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same | |
| MY134783A (en) | Rho-kinase inhibitors | |
| MY142915A (en) | Rho-kinase inhibitors | |
| HK1080466A1 (zh) | 用於治療過度增生疾病的稠合三環雜環 | |
| WO2005021497A3 (en) | Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones | |
| TNSN06315A1 (en) | Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of type 2 diabetes | |
| MXPA04003439A (es) | Compuestos de maleimida 3,4 disustituidos como antagonistas de receptor de quimiocina cxc. | |
| BG105270A (en) | Tetrahydropyridoethers | |
| WO2004108713A8 (en) | Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents | |
| WO2001035950A3 (en) | Benzamide therapeutics and methods for treating inflammatory bowel disease | |
| WO2005009367A3 (en) | Treatment of diseases with kinase inhibitors | |
| MXPA03007423A (es) | Derivados de epotilona para tratamiento de tumores refractarios. | |
| MXPA03003845A (es) | Benzo'b! tiofenos y benzo'd! isotiazoles bajos en colesterol. | |
| YU12003A (sh) | Novi derivati aminocikloheksana | |
| AU7545000A (en) | N-acyl homoserine lactones for the treatment of cardiac tachyarrhythmias, ischaemic heart disease or congestive heart failure | |
| ZA9810215B (en) | 2-Aryl-3-Aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome. | |
| MXPA04005907A (es) | Derivados de aminociclohexano heteroarilsustituidos. | |
| CA2431100A1 (en) | Dihydroindole and tetrahydroquinoline derivatives | |
| WO2002006189A3 (en) | Aniline derivatives | |
| AU2002249947A1 (en) | Inhibition of protein-phosphatases for the treatment of heart failure | |
| WO2002020483A8 (en) | Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors | |
| WO2001002358A3 (en) | Cyclized amide derivatives for treating or preventing neuronal damage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |